Skip to content
value.today

Atea Pharmaceuticals, Inc.: insider trading

97 trades by 16 directors, officers and 10% owners since 2020, from their SEC Form 4 and 5 filings.

Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$168 K
3 sales by 1 insider
Bought, 3 months
$0
0 purchases
Sold, 3 months
$168 K
3 sales

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

$81 K-$1.0 M$0Feb 2024: bought $0 (0 trades), sold $488 K (6 trades)Feb 24Jun 2024: bought $0 (0 trades), sold $65 K (2 trades)JunSep 2024: bought $0 (0 trades), sold $234 K (3 trades)SepDec 2024: bought $0 (0 trades), sold $1.0 M (1 trades)DecJan 2025: bought $81 K (2 trades), sold $0 (0 trades)Jan 25May 2025: bought $25 K (1 trades), sold $0 (0 trades)MayNov 2026: bought $0 (0 trades), sold $168 K (3 trades)Nov
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (16)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

Atea Pharmaceuticals, Inc. insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
Bruce PolskyDirector158,580—$168 K
Barbara Gayle DuncanDirector92,350——
Bruno LucidiDirector142,350——
Franklin M. BergerDirector536,097——
Jerome M. AdamsDirector92,350——
Polly A. MurphyDirector121,745——
Andrea CorcoranSee Remarks823,576——
Jean-Pierre SommadossiPresident, CEO, and Chairman, Director767,830——
Janet Mj HammondChief Development Officer127,665——
John VavrickaChief Commercial Officer82,594——
Maria Arantxa HorgaChief Medical Officer96,086——
Wayne FosterEVP, Chief Accounting Officer79,329——
Andrew A. F. HackDirector———
Chung K. Chu10% owner1.18 M——
Cormorant Asset Management, LPFormer 10% Owner———
Rock Springs Capital Master Fund LP10% owner———

Trades#

Atea Pharmaceuticals, Inc.: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Bruce PolskyDirectorOption exercise+18,252$1.240$23 K176,832Form 4
filed Bruce PolskyDirectorSell-18,252$3.950$72 K158,580Form 4
filed Bruce PolskyDirectorOption exercise+8,720$1.240$11 K167,300Form 4
filed Bruce PolskyDirectorSell-8,720$4.032$35 K158,580Form 4
filed Bruce PolskyDirectorOption exercise+48,028$1.240$60 K172,834Form 4
filed Bruce PolskyDirectorSell-14,254$4.268$61 K158,580Form 4
filed Franklin M. BergerDirectorOption exercise+29,600——536,097Form 4
filed Bruce PolskyDirectorOption exercise+29,600——124,806Form 4
filed Polly A. MurphyDirectorOption exercise+29,600——121,745Form 4
filed Bruno LucidiDirectorOption exercise+29,600——142,350Form 4
filed Jerome M. AdamsDirectorOption exercise+29,600——92,350Form 4
filed Barbara Gayle DuncanDirectorOption exercise+29,600——92,350Form 4
filed Polly A. MurphyDirectorBuyamended+6,100$4.170$25 K92,145Form 4/A
filed Andrea CorcoranSee RemarksOption exercise+60,000$1.240$74 K823,576Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorOption exercise+300,000$1.240$372 K767,830Form 4
filed Janet Mj HammondChief Development OfficerOption exercise+58,050——141,801Form 4
filed Wayne FosterEVP, Chief Accounting OfficerOption exercise+41,333——91,461Form 4
filed Andrea CorcoranSee RemarksOption exercise+54,866——779,680Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorOption exercise+272,983——573,923Form 4
filed John VavrickaChief Commercial OfficerOption exercise+42,083——94,164Form 4
filed Maria Arantxa HorgaChief Medical OfficerOption exercise+51,283——112,159Form 4
filed Janet Mj HammondChief Development OfficerShares withheld for tax-14,136$4.240$60 K127,665Form 4
filed Andrea CorcoranSee RemarksShares withheld for tax-16,104$4.240$68 K763,576Form 4
filed John VavrickaChief Commercial OfficerShares withheld for tax-11,570$4.240$49 K82,594Form 4
filed Wayne FosterEVP, Chief Accounting OfficerShares withheld for tax-12,132$4.240$51 K79,329Form 4
filed Maria Arantxa HorgaChief Medical OfficerShares withheld for tax-16,073$4.240$68 K96,086Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorShares withheld for tax-106,093$4.240$450 K467,830Form 4
filed Bruno LucidiDirectorOption exercise+29,600——112,750Form 4
filed Polly A. MurphyDirectorOption exercise+29,600——86,045Form 4
filed Franklin M. BergerDirectorOption exercise+29,600——506,497Form 4
filed Barbara Gayle DuncanDirectorOption exercise+29,600——62,750Form 4
filed Bruce PolskyDirectorOption exercise+29,600——95,206Form 4
filed Jerome M. AdamsDirectorOption exercise+29,600——62,750Form 4
filed Polly A. MurphyDirectorBuy+6,100$4.170$25 K92,145Form 4
filed John VavrickaChief Commercial OfficerOption exercise+33,333——54,848Form 4
filed Wayne FosterEVP, Chief Accounting OfficerOption exercise+33,333——54,190Form 4
filed Andrea CorcoranSee RemarksOption exercise+44,367——722,909Form 4
filed Maria Arantxa HorgaChief Medical OfficerOption exercise+41,533——67,197Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorOption exercise+173,467——290,024Form 4
filed Janet Mj HammondChief Development OfficerOption exercise+46,800——84,272Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorGrant or award+99,517——389,541Form 4
filed Maria Arantxa HorgaChief Medical OfficerGrant or award+9,750——76,947Form 4
filed Andrea CorcoranSee RemarksGrant or award+10,500——733,409Form 4
filed Wayne FosterEVP, Chief Accounting OfficerGrant or award+8,000——62,190Form 4
filed Janet Mj HammondChief Development OfficerGrant or award+11,250——95,522Form 4
filed John VavrickaChief Commercial OfficerGrant or award+8,750——63,598Form 4
filed Wayne FosterEVP, Chief Accounting OfficerShares withheld for tax-12,062$3.060$37 K50,128Form 4
filed John VavrickaChief Commercial OfficerShares withheld for tax-11,517$3.060$35 K52,081Form 4
filed Andrea CorcoranSee RemarksShares withheld for tax-16,102$3.060$49 K717,307Form 4
filed Maria Arantxa HorgaChief Medical OfficerShares withheld for tax-16,071$3.060$49 K60,876Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorShares withheld for tax-88,601$3.060$271 K300,940Form 4
filed Janet Mj HammondChief Development OfficerShares withheld for tax-14,134$3.060$43 K81,388Form 4
filed Franklin M. BergerDirectorBuyamended+10,000$3.360$34 K476,897Form 4/A
filed Franklin M. BergerDirectorBuy-10,000$3.360$34 K476,897Form 4
filed Franklin M. BergerDirectorBuyamended+15,000$3.190$48 K466,897Form 4/A
filed Franklin M. BergerDirectorBuy-15,000$3.190$48 K466,897Form 4
filed Franklin M. BergerDirectorSell-359,606$2.850$1.0 M451,897Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorSell10b5-1 plan · indirect-1,841$4.000$7 K5.87 MForm 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorSell10b5-1 plan · indirect-22,187$4.030$89 K5.87 MForm 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorSell10b5-1 plan · indirect-33,941$4.050$137 K5.89 MForm 4
filed Bruce PolskyDirectorSell-17,544$3.490$61 K65,606Form 4
filed Jerome M. AdamsDirectorOption exercise+33,150——33,150Form 4
filed Polly A. MurphyDirectorOption exercise+33,150——56,445Form 4
filed Barbara Gayle DuncanDirectorOption exercise+33,150——33,150Form 4
filed Franklin M. BergerDirectorOption exercise+33,150——811,503Form 4
filed Bruce PolskyDirectorOption exercise+33,150——83,150Form 4
filed Bruno LucidiDirectorOption exercise+33,150——83,150Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorSell10b5-1 plan · indirect-1,006$4.000$4 K5.92 MForm 4
filed John VavrickaChief Commercial OfficerSell10b5-1 plan-11,819$3.840$45 K21,515Form 4
filed Andrea CorcoranSee RemarksSell10b5-1 plan-15,843$3.840$61 K670,208Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorSell10b5-1 plan-56,910$3.850$219 K116,557Form 4
filed Janet Mj HammondChief Development OfficerSell10b5-1 plan-14,029$3.840$54 K35,362Form 4
filed Maria Arantxa HorgaChief Medical OfficerSell10b5-1 plan-15,870$3.840$61 K25,664Form 4
filed Wayne FosterEVP, Chief Accounting OfficerSell10b5-1 plan-12,477$3.840$48 K20,857Form 4
filed John VavrickaChief Commercial OfficerOption exercise+33,334——33,334Form 4
filed Andrea CorcoranSee RemarksOption exercise+44,367——686,051Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorOption exercise10b5-1 plan+173,467——173,467Form 4
filed Janet Mj HammondChief Development OfficerOption exercise+46,800——49,391Form 4
filed Maria Arantxa HorgaChief Medical OfficerOption exercise+41,534——41,534Form 4
filed Wayne FosterEVP, Chief Accounting OfficerOption exercise+33,334——33,334Form 4
filed Franklin M. BergerDirectorSell-16,166$5.160$83 K778,353Form 4
filed Franklin M. BergerDirectorSell-25,500$5.150$131 K794,519Form 4
filed Polly A. MurphyDirectorBuy+12,000$8.570$103 K23,295Form 4
filed Cormorant Asset Management, LPFormer 10% OwnerConversionindirect+6.41 M——6.41 MForm 4
filed Rock Springs Capital Master Fund LP10% ownerConversionindirect+1.41 M——1.41 MForm 4
filed Rock Springs Capital Master Fund LP10% ownerConversionindirect+282,403——282,403Form 4
filed Rock Springs Capital Master Fund LP10% ownerBuyindirect+242,708$24.00$5.8 M1.65 MForm 4
filed Rock Springs Capital Master Fund LP10% ownerBuyindirect+7,292$24.00$175 K289,695Form 4
filed Andrew A. F. HackDirectorConversionindirect+5.37 M——5.37 MForm 4
filed John VavrickaChief Commercial OfficerConversionindirect+82,508——82,508Form 4
filed Franklin M. BergerDirectorConversion+759,606——778,353Form 4
filed Chung K. Chu10% ownerConversion+176,862——1.18 MForm 4
filed Andrea CorcoranSee RemarksConversion+133,004——633,004Form 4
filed Jean-Pierre SommadossiPresident, CEO, and Chairman, DirectorConversionindirect+750,000——5.92 MForm 4
filed Polly A. MurphyDirectorConversionindirect+11,295——11,295Form 4
filed Franklin M. BergerDirectorBuy+41,666$24.00$1000 K820,019Form 4
filed Andrew A. F. HackDirectorBuyindirect+250,000$24.00$6.0 M5.62 MForm 4

Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice